Symmetric dimethylation of poly-GR correlates with disease duration in C9orf72 FTLD and ALS and reduces poly-GR phase separation and toxicity

Lauren M. Gittings,Steven Boeynaems,Daniel Lightwood,Alison Clargo,Sarfaraj Topia,Lisa Nakayama,Claire Troakes,David M. A. Mann,Aaron D. Gitler,Tammaryn Lashley,Adrian M. Isaacs
DOI: https://doi.org/10.1007/s00401-019-02104-x
IF: 15.887
2019-12-12
Acta Neuropathologica
Abstract:A GGGGCC repeat expansion in <em class="EmphasisTypeItalic">C9orf72</em> is the most common genetic cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Pathologically, patients are characterised by TDP-43 pathology and distinct inclusions containing dipeptide repeat proteins (DPRs) that are produced by repeat associated non-ATG initiated translation of the repeat expansion. This produces five different DPRs: poly-GA, poly-GR poly-PR poly-AP and poly-GP. Poly-GR and poly-PR have been shown to be highly toxic in in vitro and in vivo models, but the mechanisms are not entirely clear [<span class="CitationRef"><a href="#CR1">1</a></span>]. We investigated whether methylation of arginine residues in poly-GR (which is much more abundant than poly-PR) contributes to disease pathogenesis. Three types of arginine methylation can occur, monomethylarginine (MMA), or dimethylarginine in a symmetric (SDMA) or asymmetric (ADMA) confirmation. ADMA is the most prevalent modification with MMA and SDMA occurring at approximately 20–50% that of ADMA [<span class="CitationRef"><a href="#CR2">2</a></span>]. The importance of arginine methylation in FTD and ALS has recently come to light as methylation of arginine residues within the FTD/ALS-linked proteins FUS and hnRNPA2 is an important regulator of their liquid–liquid phase transition [<span class="CitationRef"><a href="#CR7">7</a></span>].
pathology,neurosciences,clinical neurology
What problem does this paper attempt to address?